Regarding the expression of the prognostic-relevant genes GSK3B and CTNNB1, no statistically significant differences were observed between the pre- and the post-therapeutic tumour samples (Table 5 and Tables S2 and S3). The gene discussed is CTNNB1; the disease is neoplasm.